Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2015

Open Access 01-12-2015 | Poster presentation

MiBalert, a realtime alert of multidrug-resistant bacteria in the electronic medical record

Authors: B Olesen, K Rasmussen, M Voldstedlund

Published in: Antimicrobial Resistance & Infection Control | Special Issue 1/2015

Login to get access

Excerpt

When patients are readmitted or transferred between departments or hospitals, information on multiresistant microorganisms is often recognized late or lost, resulting in infection or colonization of fellow patients or even hospital outbreaks. Currently, the hospitals of the Capital region, covering 1.8 million inhabitants, face an outbreak of vancomycin resistant Enterococcus fæcium (VRE). All hospitals share the same EHR system. …
Literature
1.
go back to reference Voldstedlund M, Haarh M, Molbak K, MiBa Board of Representatives: The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014, 19: 20667-PubMed Voldstedlund M, Haarh M, Molbak K, MiBa Board of Representatives: The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014, 19: 20667-PubMed
Metadata
Title
MiBalert, a realtime alert of multidrug-resistant bacteria in the electronic medical record
Authors
B Olesen
K Rasmussen
M Voldstedlund
Publication date
01-12-2015
Publisher
BioMed Central
DOI
https://doi.org/10.1186/2047-2994-4-S1-P201

Other articles of this Special Issue 1/2015

Antimicrobial Resistance & Infection Control 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine